Immunologist Jon Yewdell joins Vincent and Rich to discuss immune responses in the context of infection with SARS-CoV-2. Click arrow to play Download TWiV 597 (69 MB .mp3, 115 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv
TWiV covers trials of hydroxychloroquine and convalescent plasma therapy for COVID-19, and answers listener questions on blood tests for antibodies, cross-protection among coronaviruses, acquiring infection from food or the gas pump, face masks containing copper, and much more. Click arrow to play Download TWiV 596 (73 MB .mp3, 121 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show …
Daniel Griffin MD joins TWiV from a hospital parking lot to provide updates on COVID-19 diagnostics, clinical picture, and therapeutics, and then the TWiV team continues coverage of the coronavirus pandemic caused by SARS-CoV-2. Click arrow to play Download TWiV 595 (71 MB .mp3, 117 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Show notes at microbe.tv/twiv
by Helen Stillwell Helen is a research associate in David Hafler€™s immunobiology lab at Yale University; previously, she worked on poxviruses at Tonix Pharmaceuticals, and she plans to apply to PhD programs in virology this year. RT-PCR Diagnostics As cases of COVID-19 continue to rise, diagnostic testing has been a principal topic of discussion. Typically, …
On COVID-19 Testing: How it Works, Shortages, and Innovation Read More »
I’ve been delinquent in posting recent episodes of This Week in Virology here. They are all focused on SARS-CoV-2 and the disease it causes, COVID-19. Here is a list: TWiV Special: Coronavirus update with Mark Denison, MD Pediatric infectious disease physician and coronavirologist Mark Denison joins Vincent for a discussion of COVID-19 and SARS-CoV-2 with …
Chloroquine (and a derivative, hydroxychloroquine) has been used for years in the treatment of malaria. The drug is also known to block the entry of many viruses into cells. A small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients.
